The Dynamiker cryptococcal antigen lateral flow assay is an accurate, rapid and cost effective test comparable to culture for detection of cryptococcal meningitis
Journal of Medical Microbiology · 25.06.2026 · 75 (6)
DOI: 10.1099/jmm.0.002173 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Medical Microbiology, erschienen am 25.06.2026. Verfasst von Maddy Nagwovuma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, Antigens, Fungal, Cryptococcus, Chromatography, Affinity. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Makerere University Research and Innovation Grant, National Institutes of Health, European and Developing Countries Clinical Trials Partnership.
Abstract (Originalsprache)
Introduction
Cryptococcal meningitis (CM) is a leading cause of mortality among people living with human immunodeficiency virus (HIV) in Sub-Saharan Africa, requiring rapid diagnosis. Although the Food and Drug Administration (FDA)-approved Dynamiker cryptococcal antigen lateral flow assay (CrAg LFA) offers a potential point-of-care solution, its use remains limited in high-burden settings. Hypothesis/Gap statement: Despite FDA approval of Dynamiker CrAg LFA for the diagnosis of CM, the underutilization of the test in settings with a high burden of CM is of particular concern. Therefore, there is a need to validate its performance for the diagnosis of CM.
Aim
To evaluate the diagnostic performance, turnaround time and cost-effectiveness of the Dynamiker CrAg LFA for CM, using cerebrospinal fluid (CSF) culture as the reference standard. Methodology: Stored CSF samples from 200 HIV-positive patients with suspected or confirmed CM ( n =245) were tested using the Dynamiker CrAg LFA. Diagnostic metrics were calculated and compared to CSF fungal culture. Time to result and average test cost were also assessed.
Results
The Dynamiker CrAg LFA showed a sensitivity of 100% and specificity of 84.9%, with strong agreement (κ=0.83) with CSF culture. Median time to result was 30 s compared to 3 days for culture. The average cost per test was USD 3.41 versus USD 19.80–22.40 for CSF culture.
Conclusion
The Dynamiker CrAg LFA is a rapid, accurate and affordable diagnostic tool for CM and holds promise for broader implementation in resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
- Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Förderung
- Makerere University Research and Innovation Grant
- National Institutes of Health
- European and Developing Countries Clinical Trials Partnership
Zitieren
APA
Nagwovuma, M., Kwizera, R., Meya, D. B., & Achan, B. (2026). The Dynamiker cryptococcal antigen lateral flow assay is an accurate, rapid and cost effective test comparable to culture for detection of cryptococcal meningitis. Journal of Medical Microbiology, 75(6). https://doi.org/10.1099/jmm.0.002173
Vancouver
Nagwovuma M, Kwizera R, Meya DB, Achan B. The Dynamiker cryptococcal antigen lateral flow assay is an accurate, rapid and cost effective test comparable to culture for detection of cryptococcal meningitis. Journal of Medical Microbiology. 2026;75(6). doi:10.1099/jmm.0.002173
BibTeX
@article{Nagwovuma2026,
author = {Nagwovuma, Maddy and Kwizera, Richard and Meya, David Bisagaya and Achan, Beatrice},
title = {The Dynamiker cryptococcal antigen lateral flow assay is an accurate, rapid and cost effective test comparable to culture for detection of cryptococcal meningitis},
journal = {Journal of Medical Microbiology},
year = {2026},
volume = {75},
number = {6},
doi = {10.1099/jmm.0.002173}
}
EUVIMED